Boardroom Alpha
Boardroom Alpha
GNSS · Current Report (Form 8-K) · Filed June 12, 2026

Genasys Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 12, 2026
Period
Jun 9, 2026
Ticker
GNSS
Accession
0001193125-26-269389
Boardroom Alpha · Filing insights

Genasys secures an unsecured $4.3M loan from Maran Partners at 18% interest, due Sept 14, 2026, with fees.

About Genasys Inc
Market cap
$76M
1Y TSR
−2.1%
3Y TSR
−18.1%
Board grade
B+
Sector
Technology
Last annual meeting: Mar 17, 2026 · View full Genasys Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 09, 2026

 

 

Genasys Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-24248

87-0361799

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

16262 West Bernardo Drive

 

San Diego, California

 

92127

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 858 676-1112

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, $0.00001 par value per share

 

GNSS

 

NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 1.01 Entry into a Material Definitive Agreement.

On June 9, 2026, Genasys Inc., a Delaware corporation (the “Company”), entered into a Loan Agreement (the “Loan Agreement”) with Maran Partners Fund, LP, a Delaware limited partnership (the “Lender”), pursuant to which the Lender extended an unsecured term loan to the Company in the principal amount of $4.3 million (the “Loan”). The closing under the Loan Agreement also occurred on June 9, 2026. The proceeds of the Loan, net of the origination fee (as described below) and closing costs, will be used solely for working capital and general corporate purposes.

Under the Loan Agreement, the Company is obligated to make monthly payments of accrued and unpaid interest, with all unpaid principal, accrued and unpaid interest, fees and costs due and payable on September 14, 2026. The interest rate under the Loan Agreement is 18% per annum (the “Fixed Rate”). Upon the occurrence and continuation of an Event of Default (as defined in the Loan Agreement), the unpaid principal balance of the Loan will accrue interest at a rate equal to the Fixed Rate plus an additional 5% per annum. In connection with the closing of the Loan, the Company paid an origination fee of $301,000, which was deducted from the Loan proceeds. In addition, the Loan Agreement provides for an exit fee payable upon the repayment in full of the Loan equal to $64,500 if the Loan is repaid on or before July 13, 2026, and $150,500 if the Loan is repaid thereafter.

The Loan Agreement contains customary representations and warranties of the Company, affirmative and negative covenants (including, without limitation, restricting the Company from certain distributions, indebtedness, fundamental changes, sales of assets, and redemptions), Events of Default (including a change of control) and remedies thereupon, indemnification obligations of the Company, and other obligations and rights of the parties. The Loan Agreement also provides for mandatory prepayment of the Loan upon the occurrence of certain events, including a change of control of the Company, certain asset sales outside the ordinary course of business, and certain equity issuances. The Company may prepay the Loan without premium or penalty, in whole or in part, in increments of $250,000, upon at least 30 days’ advance written notice to the Lender.

The foregoing description of the Loan Agreement is qualified by reference to the full text of the Loan Agreement, which is filed as Exhibit 10.1 hereto and incorporated herein by reference. The Loan Agreement has been included to provide investors with information regarding its terms. The representations, warranties and covenants contained in the Loan Agreement were made only for purposes of the Loan Agreement and as of specific dates, were solely for the benefit of the Lender, are subject to limitations agreed upon by the parties to the Loan Agreement.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 2.03.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number

 

Description

 

 

 

10.1

 

Loan Agreement, dated as of June 9, 2026, between Genasys Inc. and Maran Partners Fund, LP.

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Genasys Inc.

 

 

 

 

Date:

June 12, 2026

By:

/s/ Cassandra L. Hernandez-Monteon

 

 

 

Cassandra L. Hernandez-Monteon
Chief Financial Officer

 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Genasys Inc (GNSS)

Reference

Frequently asked questions

When did Genasys Inc file this 8-K?
Genasys Inc (GNSS) filed this Current Report (Form 8-K) with the SEC on June 12, 2026. The accession number assigned by EDGAR is 0001193125-26-269389.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Genasys secures an unsecured $4.3M loan from Maran Partners at 18% interest, due Sept 14, 2026, with fees. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Genasys Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Genasys Inc has filed under CIK 924383, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer